HANGZHOU, China, Jan. 1, 2024 /PRNewswire/ — “When I recall the south of the lower reaches of the Yangtze River (Jiangnan), Hangzhou brings back most of my memories, and when it comes to Hangzhou, Binjiang District is the most impressive.” That would be the feelings for many sports officials, athletes and audience who visited the capital… Continue reading Hangzhou’s Binjiang District continues Asian Games glory with smart, charming style
Category: Newswire
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference
SUZHOU, China and ROCKVILLE, Md., Jan. 1, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it will attend the 42nd J.P. Morgan Healthcare Conference, and Dr. Dajun Yang, its Chairman and CEO, will give a presentation… Continue reading Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference
Global Times: County in E.China’s Jiangxi Province implements policies to boost tea exports
GANZHOU, China, Jan. 1, 2024 /PRNewswire/ — As the birthplace of tea, China is one of the largest tea producers in the world. Benefiting from China’s profound history of cultivating tea crops and the country’s Belt and Road Initiative (BRI), the ancient and popular drink has reached every corner of the world. The county of… Continue reading Global Times: County in E.China’s Jiangxi Province implements policies to boost tea exports
#H9meAzingMoments CON ERLING HAALAND – I PRODOTTI MIDEA RIVELANO LA LORO CONSONANZA CON I GOAL DI ERLING HAALAND
Oggi Midea ha lanciato la sua nuova campagna #H9meAzingMoments che presenta l’attaccante del Manchester City e tre volte vincitore Erling Haaland MANCHESTER, Inghilterra, 2 gennaio 2024 /PRNewswire/ — Midea oggi ha lanciato la sua nuova campagna #H9meAzingMoments che presenta l’attaccante del Manchester City e tre volte vincitore Erling Haaland. Continue Reading #H9meAzingMoments WITH ERLING HAALAND… Continue reading #H9meAzingMoments CON ERLING HAALAND – I PRODOTTI MIDEA RIVELANO LA LORO CONSONANZA CON I GOAL DI ERLING HAALAND
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
BEIJING, Jan. 1, 2024 /PRNewswire/ — The Xinhua-Yushu Wild Cordyceps Sinensis Price Index was officially released on Dec. 27th in Beijing, capital of China, indicating the accelerated development of wild cordyceps sinensis industry towards a new stage of digital, information and modern mode. Continue Reading Photo shows the launching ceremony of Xinhua-Yushu Wild Cordyceps Sinensis Price… Continue reading Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
CNOOC Limited Announces Mero2 Project Commences Production
HONG KONG, Jan. 1, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Mero2 Project has commenced production safely. Mero, Brazil’s third largest oilfield, is located in the Santos Basin pre-salt southeastern offshore Brazil. The development plan includes 4 production units, namely, Mero1, Mero2, Mero3… Continue reading CNOOC Limited Announces Mero2 Project Commences Production
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 1, 2024 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed in a Phase 3 clinical trial (GLORY-2) of higher… Continue reading Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – EH
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of EHang Holdings Limited (NASDAQ: EH) between January 20, 2022 and November 6, 2023, both dates inclusive (the “Class Period”), of the important February 2, 2024 lead plaintiff deadline in the securities class action… Continue reading ROSEN, TRUSTED INVESTOR COUNSEL, Encourages EHang Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – EH
ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN securities during… Continue reading ROSEN, A LEADING NATIONAL FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DG
NEW YORK, Jan. 1, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dollar General Corporation (NYSE: DG) between May 28, 2020 and August 30, 2023, both dates inclusive (the “Class Period”), of the January 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Dollar… Continue reading ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DG